Oncimmune Holdings PLC PUBLIC DISCLOSURE OF TRANSACTIONS BY PDMR (6216Q)

TIDMONC

RNS Number : 6216Q

Oncimmune Holdings PLC

30 November 2016

30 November 2016

Oncimmune Holdings plc

("Oncimmune" or the "Company")

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PDMR

Oncimmune Holdings plc (AIM: ONC.L), a leading early cancer detection company developing and commercialising its proprietary EarlyCDT(R) platform technology, today announces that on 30 November 2016, options over ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") were awarded to Dan Calvo, President of Oncimmune (USA) LLC, a PDMR, as well as to certain other US staff, under the Company's Oncimmune Holdings Plc Incentive Stock Option Plan (as amended from the Oncimmune Limited Incentive Stock Option Plan that became effective 27 July 2009) as follows:

 
 Name         Position            Number of        Option           Interest 
                                   share options    exercise         in issued 
                                   awarded          price per        share capital 
                                                    share (pence)    (%) 
-----------  ------------------  ---------------  ---------------  --------------- 
              President of 
               Oncimmune (USA) 
 Dan Calvo     LLC                        10,151            118.5             0.02 
-----------  ------------------  ---------------  ---------------  --------------- 
 

The options are subject to the rules of the Incentive Stock Option Plan and vest in five equal annual parts, the first fifth vesting on 29 November 2017 and each year thereafter for a further four years, subject to continued employment. The options are exercisable at 118.5 pence, being the mid-market closing price of the Ordinary Shares on 29 November 2016

For further information:

Oncimmune Holdings plc

Geoffrey Hamilton-Fairley, Chief Executive Officer

[e-mail]

Zeus Capital Limited (Nominated Adviser and Broker)

Phil Walker, Giles Balleny, Dominic Wilson

[phone]

Media enquiries:

Consilium Strategic Communications

Chris Gardner, Mary-Jane Elliott, Matthew Neal, Lindsey Neville

[e-mail]

[phone]

 
 1     Details of the person discharging managerial responsibilities/person closely associated 
----  ---------------------------------------------------------------------------------------------------------------- 
 a)    Name                                                     Dan Calvo 
----  -------------------------------------------------------  ------------------------------------------------------- 
 2     Reason for the notification 
----  ---------------------------------------------------------------------------------------------------------------- 
                                                                President of Oncimmune (USA) LLC 
  a)    Position/status 
----  -------------------------------------------------------  ------------------------------------------------------- 
 b)    Initial notification/Amendment                           Initial Notification 
----  -------------------------------------------------------  ------------------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, auction platform, auctioneer 
        or auction monitor 
----  ---------------------------------------------------------------------------------------------------------------- 
 a)    Name                                                     Oncimmune Holdings plc 
----  -------------------------------------------------------  ------------------------------------------------------- 
 b)    LEI                                                      N/A 
----  -------------------------------------------------------  ------------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
        each type of transaction; (iii) each date; and (iv) each place where transactions have been 
        conducted 
----  ---------------------------------------------------------------------------------------------------------------- 
 a)    Description of the financial instrument, type of         options over Ordinary Shares - Oncimmune Holdings Plc 
       instrument                                               Incentive Stock Option Plan 
       Identification code 
                                                                ISIN GB00BYQ94H38 
----  -------------------------------------------------------  ------------------------------------------------------- 
 b)    Nature of the transaction                                Grant of options over Ordinary Shares 
----  -------------------------------------------------------  ------------------------------------------------------- 
 c)    Price(s) and volume(s)                                    Price(s)    Volume(s) 
                                                                 ----------  ---------- 
                                                                     N/A       10,151 
                                                                 ----------  ---------- 
----  -------------------------------------------------------  ------------------------------------------------------- 
 d)    Aggregated information                                    Price(s)    Volume(s) 
                                                                 ----------  ---------- 
                                                                     N/A       10,151 
                                                                 ----------  ---------- 
----  -------------------------------------------------------  ------------------------------------------------------- 
 e)    Date of the transaction                                  30 November 2016 
----  -------------------------------------------------------  ------------------------------------------------------- 
 f)    Place of the transaction                                 N/A 
----  -------------------------------------------------------  ------------------------------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHURSBRNNAAOAA

(END) Dow Jones Newswires

November 30, 2016 12:47 ET (17:47 GMT)